US Broker Ratings

Owens & Minor, Inc. (OMI) Stock Analysis: Unpacking a 119% Potential Upside in Healthcare Distribution

Owens & Minor, Inc. (NYSE: OMI) is navigating turbulent waters in the healthcare sector, yet it remains a stock that investors should keep an eye on,..

Kura Oncology, Inc. (KURA): Investor Outlook on a Promising Biotech with 189% Upside Potential

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company based in San Diego, California, is making waves in the biotechnology sector with its promising pipeline aimed..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Exploring a 71.68% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) offers a compelling narrative for investors with its significant potential upside of 71.68%. Operating within the healthcare sector, specifically in..

Capricor Therapeutics, Inc. (CAPR)

⚠️ No article content returned.

..

HealthStream, Inc. (HSTM) Stock Analysis: Unveiling a Potential 38.72% Upside for Astute Investors

HealthStream, Inc. (NASDAQ: HSTM) is making waves in the healthcare sector, offering a robust suite of Software-as-a-Service (SaaS) solutions designed to enhance the operational efficiencies of..

Celcuity Inc. (CELC) Stock Analysis: A Biotech Gem with a 10% Upside Potential Amid Innovative Cancer Therapies

Celcuity Inc. (NASDAQ: CELC), a biotechnology company rooted in the healthcare sector, has captured the attention of investors with its impressive market cap of $4.35 billion..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: A High-Upside Biotech Play with 184% Potential Growth

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is making waves in the biotechnology sector, capturing investor attention with its considerable potential upside of 184.14%. Specializing in developing..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 129.71% Potential Upside in Medical Devices

Investors seeking opportunities in the healthcare sector, particularly within the medical device industry, may find Bioventus Inc. (NASDAQ: BVS) worth considering. Despite recent market fluctuations, Bioventus..

Septerna, Inc. (SEPN) Stock Analysis: Evaluating a 23% Upside in the Biotech Sector

Septerna, Inc. (SEPN), a burgeoning name in the biotechnology sector, is catching the attention of investors with its innovative approach to treating a range of complex..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a Potential 54.84% Upside in the Biotech Sector

Pharvaris N.V. (PHVS), a Swiss-based biopharmaceutical company, is making waves in the biotechnology sector with its targeted focus on developing therapies for rare diseases, particularly bradykinin-mediated..

MBX Biosciences, Inc. (MBX) Investor Outlook: Unpacking a 138% Potential Upside

MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company, is gaining significant attention from investors, and for good reason. The company, which focuses on precision peptide..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a 209.75% Potential Upside

For investors seeking opportunities in the biotechnology sector, Vir Biotechnology, Inc. (VIR) presents an intriguing case with a staggering potential upside of 209.75% based on analyst..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Challenges with a 21% Potential Upside

Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in the healthcare sector, specializes in molecular diagnostic testing and precision medicine. With a focus on oncology, women’s..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 109.58% Potential Upside Amid Healthcare Innovations

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a pioneering player in the medical device industry, is making waves with its cutting-edge innovations in bunion correction and midfoot..

Arvinas, Inc. (ARVN) Stock Analysis: 11.73% Potential Upside in Innovative Biotech Arena

Arvinas, Inc. (NASDAQ: ARVN), a dynamic player in the biotechnology sector, is garnering significant attention from investors with its innovative approach to tackling disease-causing proteins. With..

Akso Health Group (AHG) Stock Analysis: Exploring the 415.80% Revenue Growth in the Chinese Healthcare Sector

Akso Health Group (NASDAQ: AHG), a notable player in the healthcare sector, has been catching the eye of investors with its staggering 415.80% revenue growth. Operating..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Biotechnology Innovator with a 74.59% Potential Upside

Nurix Therapeutics, Inc. (NASDAQ: NRIX), a clinical-stage biopharmaceutical company, is capturing attention in the biotechnology sector with its innovative approach to drug discovery and development. Headquartered..

Opthea Limited (OPT) Stock Analysis: A Biotech Gamble with a -70.67% Potential Downside

Opthea Limited (ASX: OPT), an intriguing player in the biotechnology sector, is currently navigating the challenging waters of clinical-stage biopharmaceutical development. With a market capitalization of..

uniQure N.V. (QURE) Stock Analysis: Investor Interest Surges with 108.53% Potential Upside

For investors on the lookout for promising opportunities in the biotechnology sector, uniQure N.V. (NASDAQ: QURE) presents a fascinating case. Based in Amsterdam, Netherlands, uniQure is..

Tourmaline Bio, Inc. (TRML) Stock Analysis: Navigating the Biotech Waters with a Promising Pipeline

Tourmaline Bio, Inc. (NASDAQ: TRML) has been making waves in the biotech sector, positioning itself as a promising player in the realm of immune and inflammatory..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds